Aytu BioPharma Inc (AYTU)

2.66 +0.05  +1.92% NASDAQ Oct 20, 12:33 USD
View Full Chart
Price Chart
View All AYTU News


View All Events


Date Type Description
11/12/2021 Earnings Results Q1 2022 Earnings Results
11/12/2021 16:30 EST Earnings Calls Q1 2022 Earnings Call
09/27/2021 Earnings Results Q4 2021 Earnings Results
09/27/2021 16:30 EST Earnings Calls Q4 2021 Earnings Call
05/17/2021 Earnings Results Q3 2021 Earnings Results
05/17/2021 16:30 EST Earnings Calls Q3 2021 Earnings Call
04/21/2021 12:00 EST AGM 2021 Annual General Meeting
02/11/2021 Earnings Results Q2 2021 Earnings Results
02/11/2021 16:30 EST Earnings Calls Q2 2021 Earnings Call
12/09/2020 Splits 1 to 10 Split
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • Description: Aytu BioPharma Inc is a specialty pharmaceutical company commercializing novel products addressing patient needs. The company markets a portfolio of prescription products addressing large therapeutic markets. The primary care portfolio includes Natesto, the only FDA-approved novel formulation of testosterone, ZolpiMist, the only FDA-approved oral spray prescription sleep aid, and Tuzistra XR, the only FDA-approved 12-hour codeine-based antitussive syrup. The pediatric portfolio includes AcipHex Sprinkle, Cefaclor, Karbinal ER, and Poly-Vi-Flor and Tri-Vi-Flor.
  • URL: https://www.aytubio.com
  • Investor Relations URL: N/A
  • HQ State/Province: Colorado
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: Nov. 12, 2021
  • Last Earnings Release: Sep. 27, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.